Arsip Akt-mTOR pathways anti-neoplastic drugs

Akt–the Mammalian Target of Rapamycin (mTOR) Pathway Inhibition Increases Cervical Cancer Cell Chemosensitivity to Active Form of Irinotecan (SN-38)

Objective: To investigate the molecular pathway of the cytotoxic effect ...

Akt-the Mammalian Target of Rapamycin (mTOR) Pathways Inhibition Increases Cervix Cancer Cells Chemosensitivity to Active Form of Irinotecan (SN-38)

Objective: To investigate the molecular pathway of the cytotoxic effect ...